Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Acute Myeloid Leukemia in the Elderly Patient: New Strategies

Acute Myeloid Leukemia in the Elderly Patient: New Strategies Although selected older adults with acute myeloid leukemia can benefit from intensive therapies, recent evidences support the use of lower-intensity therapies (hypomethylating agents or low-dose cytarabine) in most of these patients and emphasize the importance of tolerability and quality of life. Individualized approaches to treatment decision-making beyond consideration of chronologic age alone should therefore be considered. One promising strategy is to combine low-intensity treatments with novel agents. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology and Therapy Springer Journals

Acute Myeloid Leukemia in the Elderly Patient: New Strategies

Oncology and Therapy , Volume 3 (2) – Jul 4, 2015

Loading next page...
 
/lp/springer-journals/acute-myeloid-leukemia-in-the-elderly-patient-new-strategies-Z33bYoX3LB

References (88)

Publisher
Springer Journals
Copyright
Copyright © 2015 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine
ISSN
2366-1070
eISSN
2195-6022
DOI
10.1007/s40487-015-0006-7
Publisher site
See Article on Publisher Site

Abstract

Although selected older adults with acute myeloid leukemia can benefit from intensive therapies, recent evidences support the use of lower-intensity therapies (hypomethylating agents or low-dose cytarabine) in most of these patients and emphasize the importance of tolerability and quality of life. Individualized approaches to treatment decision-making beyond consideration of chronologic age alone should therefore be considered. One promising strategy is to combine low-intensity treatments with novel agents.

Journal

Oncology and TherapySpringer Journals

Published: Jul 4, 2015

There are no references for this article.